Gilead Sciences, Inc. (GILD) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $151.00 -0.15%
EPS Growth %: -14.2%
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -14.2%
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q2 EPS of $0.99, $0.04 better than the analyst estimate of $0.95. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.29 billion.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- BlackRock’s Rosenberg says inflation data key after jobs beat
- JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
